Tema 14. Tratamiento de las infecciones por enterobacterias productoras de BLEE.
Tema 14. Tratamiento de las infecciones por enterobacterias productoras de BLEE.
Recursos del bloque
1 Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovate Therapies in Sepsis.
THE ACCP/SCCM CONSENSUS CONFERENCE COMMITTEE: Roger C., Bone, Chairman; Robert A. Balk, Frank B R. Philip Dellinger, Alan M. Fein, William A. Knaus; Roland M. H. Schein, William J. Sibbald, M. .2 A Multinational, Preregistered Cohort Study of -Lactam/-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum--Lactamase-Producing Enterobacteriaceae.
Belén Gutiérrez-Gutiérrez, Salvador Pérez-Galera, Elena Salamanca, Marina de Cueto, Esther Calbo, Benito Almirante, Pierluigi Viale, Antonio Oliver, Vicente Pintado, Oriol Gasch, Luis Martínez-Martínez, Johann Pitout, Murat Akova, Carmen Peña, José Molina, Alicia Hernández, Mario Venditti, Nuria Prim, Julia Origüen, German Bou, Evelina Tacconelli, Mario Tumbarello, Axel Hamprecht, Helen Giamarellou, Manel Almela, Federico Pérez, Mitchell J. Schwaber, Joaquín Bermejo, Warren Lowman, Po-Ren Hsueh, Marta Mora-Rillo, Clara Natera, Maria Souli, Robert A. Bonomo, Yehuda Carmeli, David L. Paterson, Alvaro Pascual, Jesús Rodríguez-Baño.3 Diagnosis, Prevention, and Treatment of CatheterAssociated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.
Thomas M. Hooton, Suzanne F. Bradley, Diana D. Cardenas, Richard Colgan, Suzanne E. Geerlings, James C. Rice, Sanjay Saint, Anthony J. Schaeffer, Paul A. Tambayh, Peter Tenke, and Lindsay E. Nicolle.4 Community-Onset Bacteremia Due to ExtendedSpectrum β-Lactamase–Producing Escherichia coli: Risk Factors and Prognosis.
Jesús Rodríguez-Baño,Encarnación Picónn, Paloma Gijón,José Ramón Hernádez, Maite Ruíz,Carmen Penña, Manuel Almela, Benito Almirante, Fabio Grill, Javier Colomina, Monserrat Giménez, Antonio Oliver, Juan Pablo Horcajada, Gemma Navarro,Ana Coloma,and Alvaro Pascual.5 β-Lactam/b-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts.
Jesús Rodríguez-Baño,María Dolores Navarro, Pilar Retamar,Encarnación Picón, Álvaro Pascual, and the Extended-Spectrum Beta-Lactamases–Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group.6 Bloodstream Infection Caused by Extended-Spectrum β-Lactamase–Producing Gram-Negative Bacteria: How to Define the Best Treatment Regimen?
Federico Perez and Robert A. Bonomo.7 Carbapenem Therapy Is Associated With Improved Survival Compared With PiperacillinTazobactam for Patients With ExtendedSpectrum β-Lactamase Bacteremia.
Pranita D. Tamma,Jennifer H. Han, Clare Rock, Anthony D. Harris, Ebbing Lautenbach, Alice J. Hsu, Edina Avdic, and Sara E. Cosgrove.8 Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.
Evan J. Zasowski, Kimberly C. Claeys, Abdalhamid M. Lagnf, Susan L. Davis, and Michael J. Rybak.9 Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012.
R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane ,Herwig Gerlach, Steven M. Opal,Jonathan E. Sevransky,Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, M; Mark E. Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth M. Kleinpel Derek C. Angus, Clifford S. Deutschman, Flavia R. Machado, Gordon D. Rubenfeld, Steven A. Webb, Richard J. Beale, Jean-Louis Vincent, Rui Moreno, M; and the Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup.10 ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.
E. Tacconelli1, M. A. Cataldo, S. J. Dancer, G. De Angelis, M. Falcone, U. Frank, G. Kahlmeter, A. Pan, N. Petrosillo, J. Rodrıguez-Bano, N. Singh, M. Venditti, D. S. Yokoe and B. Cookson.11 Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program.
Ricard Ferrer, Ignacio Martin-Loeches, Gary Phillips, Tiffany M. Osborn, Sean Townsend, R. Phillip Dellinger, Antonio Artigas, Christa Schorr, Mitchell M. Levy.12 Health Care–Associated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections.
N. Deborah Friedman, Keith S. Kaye, Jason E. Stout, Sarah A. McGarry, Sharon L. Trivette, Jane P. Briggs, Wanda Lamm, RN; Connie Clark, Jennifer MacFarquhar, Aaron L. Walton, L. Barth Reller, and Daniel J. Sexton.13 SPECIAL ARTICLE: CDC definitions for nosocomial infections, 1988.
Julia S.Garner, William R., Grace Emori, Teresa C. Horan, James M. Hughes.14 Duration of antibiotic treatment for acute pyelonephritis and septic urinary tract infection— 7 days or less versus longer treatment: systematic review and meta-analysis of randomized controlled trials.
Noa Eliakim-Raz, Dafna Yahav, Mical Paul and Leonard Leibovici.15 Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis.
M. Paul, Y. Dickstein, A. Raz-Pasteur.16 The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
Mervyn Singer, Clifford S. Deutschman, Christopher Warren Seymour, Manu Shankar-Hari, Djillali Annane, Michael Bauer, Rinaldo Bellomo, Gordon R. Bernard, Jean-Daniel Chiche, Craig M. Coopersmith, Richard S. Hotchkiss, Mitchell M. Levy, John C. Marshall, Greg S. Martin, Steven M. Opal, Gordon D. Rubenfeld, Tom van der Poll, Jean-Louis Vincent, Derek C. Angus.17 2001 SCCM/ESICM/ACCP/ATS/SIS. International Sepsis Definitions Conference.
Mitchell M. Levy, Mitchell P. Fink, John C. Marshall, Edward Abraham, Derek Angus, Deborah Cook, Jonathan Cohen, Steven M. Opal, Jean-Louis Vincent, Graham Ramsay.18 The SOFA (Sepsis.related Organ Failure Assessment) score to describe organ dysfunction/failure.
J.L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De Mendoca, H. Bruining, C.K. Reinhart, P.M. Suter, L.G. Thijs.